Accelerating Medicines Partnership® SCHIZOPHRENIA
News and Updates
Keep up with the latest news about the Accelerating Medicines Partnership (AMP®) SCZ program.

Past Annual Investigators Meetings (2022)


2024 Annual Investigators Meeting | 2023 | 2022

Opening Comments

Dr. Linda Brady, Director, Division Neuroscience & Basic Behavioral Science, National Institute of Mental Health
View Presentation

Welcoming Remarks

Dr. Joshua Gordon, Director of the National Institute of Mental Health
View Presentation

Structure of the Research Networks and the Data Processing, Analysis and Coordination Center (DPACC): Progress to Date

Dr. Carrie Bearden, Psychosis-Risk Outcomes Network (ProNET); Professor of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles
View Presentation

Dr. Barnaby Nelson, Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT); Head of Ultra High Risk for Psychosis Research at The Centre for Youth Mental Health, University of Melbourne and Orygen
View Presentation

Dr. Martha Shenton, Psychosis Risk Evaluation, Data Integration, and Computational Technologies (PREDICT) Data Processing, Analysis and Coordination Center (DPACC); Director, Psychiatry Neuroimaging Laboratory, Department of Psychiatry and Radiology, Brigham and Women’s Hospital, Harvard Medical School
View Presentation

Early Career Investigators

Individual Deviations in White Matter Associated with Clinical High Risk for Psychosis

Dr. Grace Jacobs, Postdoctoral Fellow, Psychosis Risk Evaluation, Data Integration, and Computational Technologies (PREDICT) Data Processing, Analysis and Coordination Center (DPACC)
View Presentation

Using Computational Modelling to Examine Auditory Oddball Processing Deficits Along the Psychosis Continuum

Dr. Ilvana Dzafic, Trajectories and Predictors in the Clinical High Risk for
Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT)

View Presentation

Development and Validation of Individualized Prediction Models in Youth at Clinical High-Risk for Psychosis

Michelle Worthington, Psychosis-Risk Outcomes Network (ProNET)
View Presentation

Open Tools for Reproducible Science

Dr. Russell Poldrack, Albert Ray Lang Professor of Psychology, Stanford University, Psychosis Risk Evaluation, Data Integration, and Computational Technologies (PREDICT) Data Processing, Analysis and Coordination Center (DPACC)
View Presentation

Translational Learning Health Care in Early Psychosis: Where Science and Engineering Meet

Dr. Robert Heinssen, Director of the Division of Services and Intervention Research at the National Institute of Mental Health
View Presentation

Back to the Future – A Journey to Identify Biomarkers for Early Psychosis Risk to Advance Development of Novel Therapeutics

Dr. Gahan Pandina, Senior Director, Janssen Research and Development
View Presentation

Leveraging Community to Support People with Schizophrenia and their Families

Dr. Sidney Hankerson, Director of Mental Health Equity Research, Icahn School of Medicine at Mount Sinai
View Presentation

Learning from Lived Experience: How Patient Perspectives Enrich Scientific Discovery

Carlos Larrauri, Board of Directors, National Alliance on Mental Illness
Brandon Staglin, President, One Mind UHR Psychosis Subject
Jeanti Profaca, Youth Research Council, Orygen
View Presentation


Last Reviewed on February 3, 2024